BiondVax Pharma (BVXV) Reports Q1 Loss of NIS0.03/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to BiondVax Pharma (BVXV) Reports Q1 Loss of NIS0.03/Share

BiondVax Announces First Quarter 2015 Financial Results

June 1, 2015 6:10 AM EDT

NES ZIONA, Israel, June 1, 2015 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV, TASE: BNDX), a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases, today announced its financial results for the first quarter of 2015 and provided a business update.

First Quarter 2015 Financial Summary

Results are in New Israel Shekels (NIS) and a convenience translation to US$ is provided, using the exchange rate of 3.98 as at March 31, 2015

Total operating expenses were NIS 1.82m ($457,000) compared with... More